FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2021/07/035136 [Registered on: 26/07/2021] Trial Registered Prospectively
Last Modified On: 23/07/2021
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Other (Specify) [curative]  
Study Design  Single Arm Study 
Public Title of Study   ayurvedic managmnet in oral cancer 
Scientific Title of Study   Role of Jatyadi Ghrita Application, Rakta Prasadak Him and Draksha avleha in oral Cancer After Conventional Anti-Cancer therapy: A Single Arm Clinical Trial 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Sharad M Porte 
Designation  Associate Proffesor 
Affiliation  National Institute of Ayurveda Jaipur 
Address  Dept. Of Agad Tantra Academic Block first floor Room no. 208 National Institute Of Ayurveda Jaipur Near Jorawar Singh Gate Amer Road Rajasthan
Dept. Of Agad Tantra Academic Block first floor Room no. 209 National Institute Of Ayurveda Jaipur Near Jorawar Singh Gate Amer Road Rajasthan
Jaipur
RAJASTHAN
302002
India 
Phone  8764038642  
Fax    
Email  sharad.agad@nia.edu.in  
 
Details of Contact Person
Scientific Query
 
Name  Dr Sharad M Porte 
Designation  Associate Proffesor 
Affiliation  National Institute of Ayurveda Jaipur 
Address  Dept. Of Agad Tantra Academic Block first floor Room no. 208 National Institute Of Ayurveda Jaipur Near Jorawar Singh Gate Amer Road Rajasthan
Dept. Of Agad Tantra Academic Block first floor Room no. 209 National Institute Of Ayurveda Jaipur Near Jorawar Singh Gate Amer Road Rajasthan

RAJASTHAN
302002
India 
Phone  8764038642  
Fax    
Email  sharad.agad@nia.edu.in  
 
Details of Contact Person
Public Query
 
Name  Rahish Ali Kureshi 
Designation  P.G. Scholar 
Affiliation  National Institute of Ayurveda Jaipur 
Address  Dept. Of Agad Tantra Academic Block first floor Room no. 209 National Institute Of Ayurveda Jaipur Near Jorawar Singh Gate Amer Road Rajasthan
Dept. Of Agad Tantra Academic Block first floor Room no. 209 National Institute Of Ayurveda Jaipur Near Jorawar Singh Gate Amer Road Rajasthan
Jaipur
RAJASTHAN
302002
India 
Phone  9667305026  
Fax    
Email  dr.rahishali5m@gmail.com  
 
Source of Monetary or Material Support  
National Institute Of Ayurveda, Jaipur 
 
Primary Sponsor  
Name  National Institute of Ayurveda Jaipur 
Address  National Institute Of Ayurveda Jaipur Near Jorawar Singh Gate Amer Road Rajasthan 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sharad M Porte  National Institute of Ayurveda Hospital, Jaipur   Dept. of agad tantra academic block first floor Room no.209 National Institute Of Ayurveda Jaipur , Rajasthan
Jaipur
RAJASTHAN 
8764038642

sharad.agad@nia.edu.in 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
National Institute Of Ayurveda , Institutional Ethical Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:C069||Malignant neoplasm of mouth, unspecified. Ayurveda Condition: ARBUDAH,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Drakshavleha  3. Drakshavleha Route of administration:- through oral route Dose:- 6gm twice a day Duration:- 30 days  
Intervention  Jatyadi Ghrita  1. Jatyadi Ghrita Route of administration:- Application of Ghrita on Ulcerative Growth Dose:- twice a day Duration:- 30 days  
Comparator Agent  NIL  NIL 
Intervention  Rakta Prasadak Him  2. Rakta Prasadak Him Route of administration:- through oral route Dose:- 40 ml. twice a day Duration:- 30 days  
 
Inclusion Criteria  
Age From  30.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details   The patients between the age group of 30 to 70 years diagnosed with oral carcinoma.
 Patient willing to sign the consent form.
 
 
ExclusionCriteria 
Details  Patients suffering from major systemic illness like diabetes, liver cirrhosis, MI,IHD, Hypertension and renal failure. 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Primary outcome/s Changes in ulcerative growth in oral cancer after conventional therapy  30 
 
Secondary Outcome  
Outcome  TimePoints 
Secondary outcome/s • Changes in quality of life in patients of oral cancer.
• Changes in conventional therapy induced oral mucositis.
 
30 days
 
 
Target Sample Size   Total Sample Size="10"
Sample Size from India="10" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   01/08/2021 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="1"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   NIL 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

ROLE OF JATYADI GHRITA APPLICATION, RAKTA PRASADAK HIM AND DRAKSHA AVLEHA   IN ORAL CANCER AFTER CONVENTIONAL ANTI-CANCER THERAPY: A SINGLE ARM CLINICAL TRIAL


PLAN FOR DISSERTATION

 

Submitted to

 

DR. SARVEPALLI RADHAKRISHNAN RAJASTHAN AYURVED UNIVERSITY JODHPUR (RAJASTHAN)

 

For the degree of

AYURVEDA VACHASPATI (M.D. Ay.- 2019-2022)

Post Graduate Department of Agad Tantra and Vyavahar Ayurveda

 

 

Under the Supervision & Guidance of

 

 

GUIDE                                           CO-GUIDE                                                               SCHOLAR

 

 

                                                                                                      

Dr. Sharad Porte

Dr. Kamal Kishor Lakhera

Dr. Rahish Ali Kureshi

M.D. (Ay.)

M.Ch. (Surgical Oncologist)

M.D. (Ay.) Scholar

Associate professor

N.I.A., Jaipur

Assistant professor                                           

S.M.S. Medical college, Jaipur

 

P.G. 1st Year

N.I.A., Jaipur

 

 

P.G. Department of Agad Tantra and Vyavahar Ayurveda

National Institute of Ayurveda, Jaipur


Application for Dissertation

To

The Registrar,

Dr. Sarvepalli Radhakrishnan Rajasthan Ayurveda University, Jodhpur.

Through: - Proper Channel

Subject: - Requesting for Registration of the dissertation for the award of Ayurveda Vachaspati [M.D. (Ay.)] in Agad Tantra and Vyavaharayurveda in the session 2019-2022. Respected Sir,

With due respect, I would like to present following particulars and also enclose the revised synopsis of the dissertation with this application for your kind perusal and permission please.

Name of Scholar -

   Dr. Rahish Ali Kureshi

Father’s Name -

   Abdul Mazeed Kureshi

Date of Birth -

   05/03/1986

Permanent add. -

   Ward no.6, Vyaparion ka mohalla, Muccam post dayara, Khandela

    District. Sikar, Rajasthan. Pin: 332709

Previous Exam Passed -

    B.A.M.S. (2011), N.I.A. (National Institute of Ayurveda), Jaipur.

Enrollment Number -

    Applied for

Name of Department -

P.G. Department of Agad Tantra

Name of Institute -

National Institute of Ayurveda, Jaipur

Language of Dissertation -    English, Sanskrit, Hindi

Title of Dissertation -             ROLE OF JATYADI GHRITA APPLICATION, RAKTA PRASADAK

HIM AND DRAKSHA AVLEHA   IN ORAL CANCER AFTER CONVENTIONAL ANTI-CANCER THERAPY: A SINGLE ARM CLINICAL TRIAL

 

Under the Supervision & Guidance of

 

GUIDE                                           CO-GUIDE                                                               SCHOLAR

 

                                                                                                      

Dr. Sharad Porte

Dr. Kamal Kishor Lakhera

Dr. Rahish Ali Kureshi

M.D. (Ay.)

M.Ch. (Surgical Oncologist)

M.D. (Ay.) Scholar

Associate professor

N.I.A., Jaipur

Assistant professor

S.M.S. Medical college, Jaipur

 

P.G. 1st Year

N.I.A., Jaipur

P.G. Department of Agad Tantra and Vyavahar Ayurveda

National Institute of Ayurveda, Jaipur


ROLE OF JATYADI GHRITA APPLICATION, RAKTA PRASADAK HIM AND DRAKSHA AVLEHA   IN ORAL CANCER AFTER CONVENTIONAL ANTI-CANCER THERAPY: A SINGLE ARM CLINICAL TRIAL

 

Introduction:

“Cancers are a large family of diseases that involve abnormal cell growth with the potential to invade or spread to other parts of the body.”

On the basis of involvement of cells, the cancer are classified into Carcinoma, Sarcoma, Leukemia, Lymphoma and Myeloma. Cancer that begins in the skin or in tissues that line or cover internal organs are carcinoma, while the growth that begins in bone, cartilage, fat, muscle, blood vessels, or other connective or supportive tissue are sarcoma. Leukemia are growth that starts in blood forming tissue, while lymphoma in cells of immune system. The cancer that begin in brain and spinal cord are gliomas, meningioma.

Global Statistics-2018 (WHO) shows that there are 18.1 million new cases all over world wide.

Indian Statistics-2018 shows 2.25 million people living with the disease, 1157294 are new cancer patients registered while 784821 are cancer related deaths.

Oral cancer, also known as mouth cancer, is cancer of the lining of the lips, mouth or upper throat. In the mouth, it most commonly starts as a painless white patch that thickens, develops red patches, an ulcer, and continues to grow. When on the lips, it commonly looks like a persistent crusting ulcer that does not heal, and slowly grows. Other symptoms may include difficult or painful swallowing, new lumps or bumps in the neck, a swelling in the mouth, or a feeling of numbness in the mouth or lips.

Risk factors include tobacco and alcohol use. With both tobacco and drinking alcohol, the risk of oral cancer is 15 times greater. Other risk factors include HPV infection, chewing Paan, and sun exposure on the lower lip. Diagnosis is made by biopsy of the concerning area, followed by investigation with CT scan, MRI, PET scan, and examination to determine if it has spread to distant parts of the body.

Oral cancer can be prevented by avoiding tobacco products, limiting alcohol use, sun protection on the lower lip, HPV vaccination, and avoidance of Paan. Treatments used for oral cancer can include a combination of surgery (to remove the tumor and regional lymph nodes), radiation therapy, chemotherapy, or targeted therapy. The types of treatments will depend on the size, locations, and spread of the cancer taken into consideration with the general health of the person.

In 2018, oral cancer occurred globally in about 355,000 people, and resulted in 177,000 deaths. Oral cancer has an overall 5 year survival rate of 65%. This varies from 84% if diagnosed when localized, compared to 66% if it has spread to the lymph nodes in the neck, and 39% if it has spread to distant parts of the body. Survival rates also are dependent on the location of the disease in the mouth.

Ayurveda is ancient medical science which has been giving the health solutions to the human race since ancient times. Though the term cancer is new for Ayurveda.

The basics principle for diagnosed and management the known or unknown diseases are well explained by using this basic principle of Ayurveda, the oral cancer can be diagnosed and treated.

Ayurveda is store of herbal, mineral and herbo-mineral medicines for various diseases including Arbuda. Though the Ayurveda has not mentioned oral cancer directly but the clinical features of oral cancer resembles as Mukhgata Dushta Vrana because of its ulcerative nature. The previous researches on herbal, mineral and herbo-mineral drugs for cancer are giving the enthusiasm in the field of role of Ayurveda therapy and drugs on cancer, as previous researches found significant. The anti-cancerous drugs like vincristine, vinblastine, paclitaxel etc. has also proven to be fruitful products scientifically and continuous drug research by medical scientist in field of development of anti-cancer drugs from natural drugs. But all these efforts are not enough as the problem is status quo and there is need to evaluate the new regimen for cancer which will be efficient and safe to the patient.

 

Need of study:

As the world wide data suggest that cancer is the 2nd largest cause of death that occur due to any disease, while on the other hand the toxic effects of chemotherapy and radiotherapy are well known for hampering to patients. In advanced stage there is no cure, no solution of cancer in any pathy till date. Ayurveda is a store of basic principles and holistic medicines. By using these basic principles and holistic medicines there is a hope to improve the patient’s condition clinically. But there is need to evaluate and prove the efficacy of the Ayurveda therapy and drugs on cancer scientifically by using medical statistics.

 

Rationale:

For this research work Jatyadi Ghrita and Rakta Prasadak Him will be used to treat this Mukhgat Dusta Vrana with special reference to ulcerative oral carcinoma wound.

Jatyadi Ghrita is mentioned in Sharangdhar Samhita Ghrita Kalpana Chapter 09/58-59. It is mentioned in the reference of Pidayukt Vrana, Dushta Vrana, Hard Varna etc. Jatyadi Ghrita contains Karanja, Chameli, Parwal, Haridra, Daruharidra, Madhuchchhishta, Madhuyasti, Kutki, Manjistha, Khas, Pipali, Tutha, Sariva and Nishotha. All the ingredient of Jatyadi Ghrita have Vrana Ropan and Shodhan properties.

Rakta Prasadak Him is a N.I.A. proprietary poly herbal drug. All the ingredients of Rakta Prasadak Him have Rakta Pitta Shamak properties, so that it will be used in this study for the Ropan of Mukhgat Dushta Vrana and for the Prasadan of Rakta. Rakta Prasadak Him contains Majistha, Usheer, Kakmachi , Bhumi amalki and Saariva. These drugs are used in cancer patient since six years in N.I.A.

Rakta Prasadak Him is a N.I.A. proprietary poly herbal drug which is being given in cancer Consultation & Treatment Unit of N.I.A., Jaipur for cancer patient hence it selected in clinical trial on a Study drug.

Draksha Avleha mainly contain Draksha and Amalaki which are best immuno-modulators. It also helps in curing chronic obstructive jaundice, liver disease, anemia, hyperacidity, indigestion. Hence it is included in this study as immuno-modulator which is need in cancer patient as well as to relieve the symptoms.

Hence the topic entitle ROLE OF JATYADI GHRITA APPLICATION, RAKTA PRASADAK HIM AND DRAKSHA AVLEHA   IN ORAL CANCER AFTER CONVENTIONAL ANTI-CANCER THERAPY: A SINGLE ARM CLINICAL TRIAL.

 

Hypothesis:

 

Null hypothesis: There is no difference between the efficacy of Jatyadi Ghrita local application along with   Rakta Prasadak Him and Draksha Avleha on symptom of oral cancer after and before treatment.

 

Aims & Objectives:

 

A)       Aim:

·       To evaluate the effect of Jatyadi Ghrita and Rakta Prasadak Him on

                    ulcerative growth in oral cancer after conventional therapy.

B)        Objectives:

·       To evalute the improvement in quality of life in patient of oral cancer.

·       To evaluate the effect of Ayurvedic medicine on conventional therapy induced oral mucositis.

 

Material & Method:

 

Study type: A single arm clinical trial.

Phase of trail: 2nd

Target sample size: 10 patients

Site/s of study: N.I.A. Hospital, Jaipur and S.M.S. Hospital, Jaipur.

Method of generating randomization sequence: computer generated.

Date of first enrolment: After the approval from ethical committee and CTRI registration.

Estimated duration of trail: 30 days.

 

Clinical study:

·       10 Known diagnosed Patients of Oral cancer will be selected from I.P.D. or O.P.D. Cancer Consultation & Treatment Unit N.I.A., Jaipur and S.M.S. hospital, Jaipur.

·       Selection of patients will be mainly based on the Biopsy or FNAC report.

·       A special research proforma will be prepared for studying the patients as well as the disease.

Clinical Group of Study:

10 Selected patients of Oral cancer.

 

Study Group:

10 patients of known case of oral cancer following conventional anti-cancer therapy     (including either Surgery, Radiotherapy or Chemotherapy),   will be given Jatyadi Ghrita and Rakta Prasadak Him along with Drakshavleha.

 

Inclusion Criteria

Ø  The patients between the age group of 30 to 70 years diagnosed with oral carcinoma.

Ø  Patient willing to sign the consent forms.

 

Exclusion Criteria

Ø  Patients suffering from major systemic illness like diabetes, liver cirrhosis, MI, IHD,

Sr.

No.

Clinical Features

Study Group

Before Study

After Study

1

Red, white or mixed red-white lesions

 

 

2

Ulcer lasting longer than three weeks

 

 

3

Pain, especially associated with the tongue

 

 

4

Swelling inside mouth or in neck area

 

 

5

Discomfort with speech and swallowing

 

 

Hypertension and renal failure.

 

Assessment of patients shows the clinical improvement in associated signs and symptoms of oral cancer following conventional anti-cancer therapy-

 

 

 

 

 

 

 

 

 

Assessment of patients shows the clinical improvement in associated signs and symptoms of Oral Mucositis following conventional anti-cancer therapy-

 

Sr.

No.

Clinical Features

Study Group

Before Study

After Study

1

Oral pain

 

 

2

Burning

 

 

3

Erythema

 

 

4

Ulcerations

 

 

5

Difficulty with mouth care regimens

 

 

6

Difficult eating, drinking and speaking

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gradation of signs and symptoms

None

Mild

Moderate

Severe

0

1

2

3

 

 

Mucositis grading according to the World Health Organization

0- Mucous membrane without change

1- Mucous membrane has mild inflammation and sometimes mild pain that does not need anti-inflammation medication

2- Point mucositis associated with mild serous, inflammatory discharge and mild pain that needs pain killer

3- Diffused and continuous mucositis with fibrous discharges and severe pain that needs pain killer

 

Assessment of QOL (quality of life) in Oral cancer:  

                             

Sr.no

QQL

Befor treatment

After Treatment

1

Physical Well being

 

 

2

Psychological well being

 

 

3

Social Well being

 

 

4

Spiritual Well being

 

 

 

 

 

 

Assessment and Grading

Never

=1

Seldom

= 2

Some Time

=3

As often as not

=4

Frequently

= 5

Very often

=6

Always

=7

 

STUDY GROUP

            JATYADI GHRITA: SHARANGDHAR SAMHITA: (Chapter 09/58-59)

 

Sr. No.

Content

Botanical name

Part used

Part

1

Karanj

Millenttia Pinnata Linn.

New leaf and Kachhe Phal

1part

2

Chameli

Jasminum officinale Linn.

Leaf

1part

3

Patol

Trichosanthes Dioica. Roxb.

Leaf

1part

4

Neem

Azadirachta Indica A. juss

Leaf

1part

5

Haridra

Curcuma longa Linn.

Kand

1part

6

Daruhldi

Berberis Aristata DC

Kand

1part

7

Yastimadhu

Glycyrrhiza Glabra Linn.

Root

1part

8

Kutki

Picrorhiza Kurrooa Royle

Root

1part

9

Sikta (Mom)

 

 

1part

10

Sariva

Hemidesmus indicus Linn.

Root

1part

11

Neela thotha (Tutth)

 

 

1 part

12

Manjista

Rubia Cardifolia Linn.

Root

1 part

13

Chandana

Santalum album Linn.

Kandsar

1 part

14

Nishoth

Operculina turpethum Linn.

Mooltwak

1 part

15

Utpal

Nelumbo nucifera Gaertn

Panchang

1 part

16

Sarpi

Ghrita

-

-

17

Khas

Chrysopogon Zizanioides Linn.

Seed

1 part

 

Preparation method- Jatyadi Ghrita will be prepared by taking one part Kalk of the each constituent in equal quantity. Then the drug will be prepared by the standard method of Ghritapak.

           Route of administration:-.Application of Ghrita on Ulcerative Growth

           Dose:- twice a day             

 Duration:- 30 days

      

RAKTA PRASADAK HIM: (N.I.A. proprietary poly herbal drug)

 

Sr. No.

Content

Botanical name

Part used

Part

1.

Majistha

Rubia cardifolia Linn.

Twak

1part

2.

Sariva

Hemidesmus indicus Linn.

Root

1part

3.

Usheer

Vetiveria zizanioidis Linn.

Kand

1part

4.

Kakmachi

Solanum nigrum Linn.

Twak and Pushpa

1part

5

Bhumi Amlaki

Phyllanthus urinaria Linn.

Panchang

1 Part

Preparation:- Rakta prasadak Him  will be prepared by taking one part of the all constituents in equal quantity. Coarse powder of these drugs will be soaked in 6 times of water for 6 to 12 hours. It will be prepared according to preparation method as described in Shastra for Him Kalpna.

Route of administration:- through oral route

Dose:- 40 ml. twice a day

Duration:- 30 days

Diet :- The diet will be modified as per Ayurveda science in both groups.

 

DRAKASHA AVLEHA:

 

Sr. No.

Content

Botanical name

Part used

Part

1

Draksha

Vitis vinifera Linn.

Fruit

768 g

2

Pippali

Piper longum Linn.

Fruit

768 g

3

Sharkara

Sugar

-

2.800 kg

4

Yashtimadhu

Glycyrrhiza glabra Linn.

Root

96 g

5

Shunthi

Zingiber officinale Roscoe

Rhizome

96 g

6

Tvakshiri

Bambusa arundinacea willd

-

96 g

7

Dhatri

Embelica officinalis Gaertn

Phalarasa

12.288 l

8

Madhu

Honey

-

768 g

 

               Dose- 6 gm. twice a day with milk after meals

               Duration- 30 days

 

Observation and Result:

A detail proforma will be created to carry out this study in a scientific way. All demographic data related to patient along with sign and symptom of disease will be noted on 1st day, 15th day and 30th day of study. The clinical efficacy of study drugs will be assessed on the basis of sign and symptom and their difference before and after treatment. The result will be presented in the form of table, graph and diagram. Data obtained during the study will be analyzed statistically by using appropriate test of significance suitable for the study.

Summary and Conclusion:

The finding as observation and result will be summarized and conclusion will be carried out on the basis of observation and result.

 

PROPOSED CONTENTS OF THE DISSERTATION

 

Present research work will be presented in the form of a thesis, which will include following Contents:

1.       Benediction

2.       Acknowledgement

3.       Introduction

4.       Review of literature

(i)                           Ayurveda Aspects of Oral Cancer and associated signs and symptoms.

(ii)                        Modern review of oral cancer.

5.       Drug Review- RAKTA PRASADAK HIM, JATYADI GHRITA, DARKSHAVLEHA.

6.       Comparative clinical trial

(i)                           Material &Methods

(ii)                        Observation & Result

7.       Discussion

8.       Summary &Conclusion

9.       Reference &Bibliography

10.   Appendix

 

 

 

 

 

GUIDE                                           CO-GUIDE                                                               SCHOLAR

 

 

                                                                                                      

Dr. Sharad Porte

Dr. Kamal Kishor Lakhera

Dr. Rahish Ali Kureshi

M.D. (Ay.)

M.Ch. (Surgical Oncologist)

M.D. (Ay.) Scholar

Associate professor

N.I.A., Jaipur

Assistant professor

S.M.S. Medical college, Jaipur

 

P.G. 1st Year

N.I.A., Jaipur

 

 

P.G. Department of Agad Tantra and Vyavahar Ayurveda

National Institute of Ayurveda, Jaipur

ROLE OF JATYADI GHRITA APPLICATION, RAKTA PRASADAK HIM AND DRAKSHA AVLEHA   IN ORAL CANCER AFTER CONVENTIONAL ANTI-CANCER THERAPY: A SINGLE ARM CLINICAL TRIAL

 

Presentation of synopsis in the form of Panchavayava Vakya

 

 

Submitted to

 

DR. SARVEPALLI RADHAKRISHNAN RAJASTHAN AYURVED UNIVERSITY JODHPUR (RAJASTHAN)

 

 

For the degree of

AYURVEDA VACHASPATI (M.D. Ay.- 2019-2022)

Post Graduate Department of Agad Tantra and Vyavahar Ayurveda

 

 

 

 

 

Under the Supervision & Guidance of

 

 

 

GUIDE                                           CO-GUIDE                                                               SCHOLAR

 

 

                                                                                                      

Dr. Sharad Porte

Dr. Kamal Kishor Lakhera

Dr. Rahish Ali Kureshi

M.D. (Ay.)

M.Ch. (Surgical Oncologist)

M.D. (Ay.) Scholar

Associate professor

N.I.A., Jaipur

Assistant professor                                           

S.M.S. Medical college, Jaipur

 

P.G. 1st Year

N.I.A., Jaipur

 

 

P.G. Department of Agad Tantra and Vyavahar Ayurveda

National Institute of Ayurveda, Jaipur

 
Close